- Home
- Publications
- Publication Search
- Publication Details
Title
Towards new TB vaccines: What are the challenges?
Authors
Keywords
-
Journal
Pathogens and Disease
Volume 74, Issue 4, Pages ftw016
Publisher
Oxford University Press (OUP)
Online
2016-04-06
DOI
10.1093/femspd/ftw016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa
- (2016) Paul L.A.M. Corstjens et al. CLINICAL BIOCHEMISTRY
- Tuberculosis
- (2016) Keertan Dheda et al. LANCET
- The transmission of Mycobacterium tuberculosis in high burden settings
- (2016) Tom A Yates et al. LANCET INFECTIOUS DISEASES
- Quest for Correlates of Protection against Tuberculosis
- (2015) Kamlesh Bhatt et al. Clinical and Vaccine Immunology
- The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis
- (2015) Gwenan M. Knight et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
- (2015) Christopher L. Karp et al. IMMUNOLOGICAL REVIEWS
- Transformative tools for tackling tuberculosis
- (2015) Jennifer L. Gardiner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment
- (2015) Jacqueline M. Cliff et al. JOURNAL OF INFECTIOUS DISEASES
- Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies
- (2015) Igor Kramnik et al. Seminars in Immunopathology
- Innovative clinical trial designs to rationalize TB vaccine development
- (2015) R.D. Ellis et al. TUBERCULOSIS
- Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis?
- (2015) Juan I. Moliva et al. VACCINE
- First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
- (2015) Angelique Kany Kany Luabeya et al. VACCINE
- A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants
- (2015) M. Tameris et al. VACCINE
- The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
- (2015) Hennie Geldenhuys et al. VACCINE
- Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
- (2015) Adam Penn-Nicholson et al. VACCINE
- Epigenetics and Proteomics Join Transcriptomics in the Quest for Tuberculosis Biomarkers
- (2015) Maria M. Esterhuyse et al. mBio
- Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study
- (2015) Louis Grandjean et al. PLOS MEDICINE
- Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
- (2015) Emily A Kendall et al. Lancet Respiratory Medicine
- Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
- (2015) Birahim Pierre Ndiaye et al. Lancet Respiratory Medicine
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
- (2015) François Spertini et al. Lancet Respiratory Medicine
- The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
- (2015) Marcela Henao-Tamayo et al. PLoS One
- Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines
- (2015) Steven G. Smith et al. PLoS One
- Immune Subdominant Antigens as Vaccine Candidates againstMycobacterium tuberculosis
- (2014) Mark T. Orr et al. JOURNAL OF IMMUNOLOGY
- Recent advances towards tuberculosis control: vaccines and biomarkers
- (2014) J. Weiner et al. JOURNAL OF INTERNAL MEDICINE
- Tuberculosis Vaccines and Prevention of Infection
- (2014) Thomas R. Hawn et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
- (2014) Suzanne T. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
- (2014) Andre S. Nell et al. PLoS One
- The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
- (2014) Michele Tameris et al. PLoS One
- Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial
- (2014) Klaus Reither et al. PLoS One
- Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries
- (2014) G. M. Knight et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of in vitro evolution on antigenic diversity of Mycobacterium bovis bacillus Calmette-Guerin (BCG)
- (2014) Richard Copin et al. VACCINE
- The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses
- (2014) Benjamin M.N. Kagina et al. VACCINE
- Sequence Diversity in the pe_pgrs Genes of Mycobacterium tuberculosis Is Independent of Human T Cell Recognition
- (2014) R. Copin et al. mBio
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- Inhibition of Mycobacterial GrowthIn Vitrofollowing Primary but Not Secondary Vaccination with Mycobacterium bovis BCG
- (2013) Helen A. Fletcher et al. Clinical and Vaccine Immunology
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
- (2013) Leanne Marsay et al. TUBERCULOSIS
- A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
- (2013) Helen McShane et al. TUBERCULOSIS
- Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis
- (2013) Crystal A. Shanley et al. TUBERCULOSIS
- Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
- (2013) Leander Grode et al. VACCINE
- Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
- (2013) Ainhoa Arbues et al. VACCINE
- Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7)
- (2013) Yuri V Efremenko et al. Human Vaccines & Immunotherapeutics
- Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study
- (2013) Myrsini Kaforou et al. PLOS MEDICINE
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and Disease
- (2013) Evelyn Guirado et al. Frontiers in Immunology
- Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response
- (2012) Jacqueline M. Cliff et al. JOURNAL OF INFECTIOUS DISEASES
- A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
- (2012) A.A. Odutola et al. VACCINE
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
- (2010) Iñaki Comas et al. NATURE GENETICS
- Development of a Murine Mycobacterial Growth Inhibition Assay for Evaluating Vaccines against Mycobacterium tuberculosis
- (2009) M. Parra et al. Clinical and Vaccine Immunology
- Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis
- (2009) Steven G. Smith et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started